David Baxley Spetzler

David Baxley Spetzler appears in our data through filings on Caris Life Sciences, Inc. shares, published by SEC (Form 4). The record holds 12 filings, for trades running from 3 March 2025 to 4 September 2026.

In open-market terms, that means 1 purchase worth €8,260 on one side and 3 sales worth €12.8M on the other. Sales outweigh purchases by €12.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants and 3 option exercises. 2026 to date brings no purchases and 3 sales.

The record was last updated on 4 September 2026 with an option exercise (€2.1M) in Caris Life Sciences, Inc. The last purchase on record was published on 10 November 2025, which is 348 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.